Trial intelligence / Profile preview

Comparative effectiveness and tolerability of haloperidol vs risperidone for delirium in advanced and terminal cancer

2010-019447-19Phase 4Terminated

Sponsor
Parc de Salut Mar
Start
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in delirium and cancer comparing Haloperidol arm with Risperidone arm (2 arms). Primary endpoint: Severity of delirium. Started Jun 2010; status: terminated.

02

Drugs

haloperidolrisperidone
03

Conditions

deliriumcancer

Beyond the preview

Go deeper on 2010-019447-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019447-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call